Larvol Delta - Agios-Showcases-RISE-UP-Phase-3-Results-at-EHA-2026-Plenary-Session-Reinforcing-Strong-AntiHemolytic-Prole-of-Mitapivat-in-Sickle-Cell-Disease

Pyrukynd (mitapivat) - Agios Pharmaceuticals

https://www.globenewswire.com/news-release/2026/06/13/3311392/31990/en/agios-showcases-rise-up-phase-3-results-at-eha-2026-plenary-session-reinforcing-strong-anti-hemolytic-profile-of-mitapivat-in-sickle-cell-disease.html

Jun 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next